The Novan Advisory Council is comprised of key opinion leaders with broad expertise in dermatology. Novan has recruited these leading and well-respected physicians based on their reputations as clinical experts to provide medical advice and drug development insight to the Company’s senior leadership team and board of directors. The maturity of the business and the stage of the pipeline products enables Novan to attract world-class dermatology leaders.
Dr. Lawrence Eichenfield, Chairman of Novan's Advisory Council, is chief of pediatric and adolescent dermatology at Rady Children’s Hospital–San Diego, vice chair of the Department of Dermatology and professor of dermatology and pediatrics at the University of California, San Diego (UCSD) School of Medicine. He has been directly involved in the development of novel topical acne, eczema and psoriasis products, and has an appreciation for the regulatory challenges in the development and launch of new chemical entities.
Advisory Council Members
Dr. Eichenfield received his medical degree from Mount Sinai School of Medicine in New York, was a pediatric resident and chief resident at Children’s Hospital of Philadelphia and completed his dermatology residency at the Hospital of the University of Pennsylvania. Dr. Eichenfield’s clinical interests include atopic dermatitis, acne, psoriasis, vascular lesions including port wine stains and hemangiomas, neonatal dermatology, laser surgery, nevi and skin signs of systemic disease. He has authored more than 300 journal articles, chapters, abstracts and books on these topics and has served as the senior editor of Neonatal and Infant Dermatology, published by Elsevier, as well as The Eczemas, published by Summit Communications. He is also editor-in-chief of Pediatric Dermatology and serves on the editorial boards of multiple journals and periodicals. In addition, Dr. Eichenfield has been honored as a member of the Alpha Omega Alpha Medical Honor Society during medical school, as a recipient of the Benjamin Ritter Award at Children’s Hospital of Philadelphia and as a recipient of excellence in teaching awards from UCSD Pediatrics, UCSD Dermatology and Rady Children’s Hospital–San Diego. He has been named one of the “Best Doctors in America” since 1994. Dr. Eichenfield is past president of the Society for Pediatric Dermatology, past board member of the American Academy of Dermatology as well as chair for the 69th Annual Meeting of the American Academy of Dermatology. Dr. Eichenfield is also a founding board member of the American Acne and Rosacea Society. He is a founder and co-chair of the Pediatric Dermatology Research Alliance (PeDRA).
Inflammatory Skin Diseases
Dr. Lisa Beck is a tenured professor of dermatology at the University of Rochester in Rochester, New York, with secondary appointments in allergy, immunology and rheumatology (medicine) and pathology. She received her undergraduate degree from Mount Holyoke College and her medical degree from the State University of New York at Stony Brook and completed a residency in dermatology at Duke University Medical Center. She has had a longstanding interest in characterizing cutaneous allergic inflammation with a specific focus on atopic dermatitis (or eczema). Her laboratory was the first to demonstrate that leukocytes’ activation status affected their in vivo responsiveness to intradermally injected chemokines. Additionally, she demonstrated that chemokines also act on structural cells, implicating chemokines as mediators of fibrosis and/or epithelial barrier repair. More recently, her laboratory has been exploring the dynamic interaction between the skin barrier and the innate and adaptive immune systems. She was the first to describe and characterize epidermal tight junction (TJ) defects in atopic dermatitis. Ongoing studies are evaluating whether these defects develop as a consequence of tissue inflammation or microbial flora, which is highly altered in AD subjects. Her laboratory has observed that several innate immune pathways including NOD2, TLR2 and 3 and adaptive immune pathways such as IL-17α enhance epidermal TJ function. Another focus of the laboratory is trying to understand the role that epithelium (keratinocytes) plays in epicutaneous allergen sensitization and vaccination. Dr. Beck’s clinical and laboratory work has been supported by grants from the National Eczema Association, National Institutes of Health (NIH), Dermatology Foundation and from biotech/pharmaceutical companies. She has been co-principal investigator of the NIH/National Institute of Allergy and Infectious Diseases-funded Atopic Dermatitis Research Network (ADRN) since 2004, which has amassed the largest registry of deeply phenotyped atopic dermatitis subjects in the world.
Dr. Brian Berman is professor emeritus of dermatology and cutaneous surgery at the University of Miami Miller School of Medicine (UMMSM). He is vice president-elect of the American Academy of Dermatology and the American Academy of Dermatology Association and vice president of the American Dermatological Association. He has held many leadership positions including vice chairman of the Department of Dermatology at The University of California, Davis and chairman of the Department of Dermatology at Mount Sinai Medical Center of Florida in Miami Beach. He is past president and founder of the National Association of Veterans Affairs Dermatologists and chaired the Dermatology Field Advisory Group for the Department of Veterans Affairs. He also serves on numerous scientific advisory/editorial boards including the European Journal of Dermatology and the Journal of Clinical and Aesthetic Dermatology.
In addition to caring for patients at Skin and Cancer Associates in Aventura, Florida, Dr. Berman teaches at the Miami Veterans Affairs Medical Center. He also serves as co-director of the Center for Clinical and Cosmetic Research where he continues his broad-based clinical research program while focusing laboratory investigations on the study of the control of scarring. He has presented at more than 300 dermatologic societies and meetings and has authored more than 250 peer-reviewed scientific and clinical articles, chapters and books. He is the recipient of the Dean’s Senior Faculty Clinical Research Award from UMMSM, was bestowed the “Scientist of the Year” Award from Sigma Xi, a Science and Research Honor Society, and is included in U.S. News and World Report’s “Best Doctors in America.”
Dr. James Del Rosso has been in private practice of dermatology and cutaneous surgery since the 1980s and has over twenty years of experience in dermatology clinical research. He holds a doctor of osteopathic medicine degree from Ohio University College of Osteopathic Medicine and is board certified in dermatology and Mohs micrographic surgery by the American Osteopathic Association (AOA) and the American Osteopathic Board of Dermatology (AOBD). Dr. Del Rosso is a past president of the American Acne & Rosacea Society, the American Society for Mohs Surgery and the American Osteopathic College of Dermatology.
In addition to his clinical practice, Dr. Del Rosso is an internationally renowned educator and speaker for the dermatology field. He has authored several recognized publications on guidelines for management of acne, rosacea, atopic dermatitis, psoriasis and skin cancer and is the co-editor of the textbook, Acne Vulgaris. Dr. Del Rosso has been the editor-in-chief of the Journal of Clinical Aesthetic Dermatology since its inception in 2005. In 2005, Dr. Del Rosso founded, and is continuing director of, the Scientific Panel for Antibiotic Use in Dermatology (SPAUD). SPAUD has held three meetings and authored scientific publications to guide clinicians on optimal antibiotic use.
Dr. Leon Kircik is a board-certified dermatologist who graduated with Alpha Omega Alpha Honors from State University of New York at the Health Sciences Center at Brooklyn after completing his undergraduate work with Phi Beta Kappa at New York University. He completed a Mohs Micrographic Surgery and Cutaneous Oncology Fellowship under the auspices of Dr. Frederick Mohs at the University of Wisconsin after completing his dermatology residency at State University of New York in Buffalo.
He currently teaches as associate clinical professor of dermatology at Indiana University Medical Center in Indianapolis as well as at Icahn School of Medicine at Mount Sinai Medical Center in New York. Dr. Kircik is also the medical director of DermResearch, PLLC and Physicians Skin Care, PLLC in Louisville, Kentucky. He has been the principal investigator of numerous clinical trials for psoriasis, acne, rosacea, atopic dermatitis, skin cancers and actinic keratosis, just to name a few.
Dr. Kircik is an author of many scientific articles, abstracts and posters. He has lectured extensively nationally and internationally on all aspects of dermatologic conditions. In addition, he serves on the advisory boards of several pharmaceutical companies as a consultant. He is on the editorial board of Journal of Drugs in Dermatology, Practical Dermatology, The Journal of Clinical & Aesthetic Dermatology and Case Report in Clinical Pathology. He volunteers for multiple local and national medical society committees.
Inflammatory Skin Diseases
Dr. Alan Menter is chair of the residency program as well as chair for Dermatology at Baylor Research Institute, Dallas, Texas. In addition to he is Principle Faculty at Texas A&M University Health Science Center, as well as clinical professor of dermatology at the University of Texas Southwestern Medical School in Dallas. In 1994, he co-authored the first gene discovery for psoriasis, published in Science in 1994. From 1996 to 2002, Dr. Menter held the position of clinical director of the National Psoriasis Foundation Gene Bank. In 2004, he helped found the International Psoriasis Council to raise international awareness of psoriasis as a serious autoimmune disease that can significantly impact quality of life. His research on psoriasis has examined everything from ultraviolet phototherapy, biologic therapy to the mapping of genetic patterns to predict if a person is at risk of developing psoriasis.
Dr. Menter has authored over 385 articles, four books and 23 book chapters. He serves as a member of the editorial board for several medical journals, including the Journal of Clinical Dermatology and Clinical and Experimental Dermatology. Dr. Menter received the Lifetime Achievement Award from the National Psoriasis Foundation in 2013 and the Dermatology Foundation annual Clark W. Finnerud award at the AAD meeting in San Francisco in 2015.
Dr. Ted Rosen is a professor of dermatology at Baylor College of Medicine and the chief of dermatology service at the Michael E. DeBakey Veterans Affairs Medical Center in Houston, TX. A native of Chicago, he is an AOA inductee and cum laude graduate of the University of Michigan Medical School. He trained in dermatology at Baylor College of Medicine. Dr. Rosen is a past president and secretary-treasurer of the Houston Dermatology Society, past vice-president of Texas Dermatological Society, past chairman and secretary-treasurer of the Dermatology Section of the Southern Medical Association, former member of the board of trustees of the Sulzberger Institute, a former member of the board of trustees of the Noah Worcester Dermatological Society and former member of the American Academy of Dermatology board of directors. He is a current member of the editorial boards of Cutis, Dermatology Online Journal, International Journal of Dermatology, Skin Therapy Letter, and UpToDate, and is the North American Editor of Global Skin Atlas. He has published over 275 peer-reviewed journal articles, 24 textbook chapters, and four medical textbooks, including the award-winning Atlas of Black Dermatology. He has lectured to over 100 hospitals and medical schools in the United States and abroad, and has been a plenary guest speaker at the national dermatology societies of Argentina, Australia, Canada, Hong Kong, Korea, and Mexico, as well as at the European Academy of Dermatology and Venereology and World Congress of Dermatology.
Bio coming soon.